A. Price

发表

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.

P. Vyas, A. Mead, T. Enver, 2011, Cancer cell.

Killer Immunoglobulin Receptor 3 DL 1-mediated recognition of Human Leukocyte Antigen B

T. Beddoe, J. Rossjohn, S. Gras, 2017 .

Cytotoxic Wave of Activated Antigen-Specific Primary EBV Infection Induces an Acute

K. Ladell, J. McLaren, E. James, 2019 .

Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells

Yong Gu Lee, Nathan H. Roy, S. Grupp, 2021, Nature Network Boston.

Key stages of bone marrow B-cell maturation are defective in patients with common variable immunodeficiency disorders.

Smita Y. Patel, M. van der Burg, E. López-Granados, 2015, The Journal of allergy and clinical immunology.

Hypoxia–Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha

C. Dive, A. Price, J. Adamski, 2013, PloS one.

Genetically distinct leukemic stem cells in human CD34− acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

P. Vyas, A. Mead, C. Craddock, 2016, The Journal of experimental medicine.

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia

I. Weissman, P. Vyas, C. Craddock, 2013, Leukemia.

Preservation of T-Cell Stemness with a Novel Expansionless CAR-T Manufacturing Process, Which Reduces Manufacturing Time to Less Than Two Days, Drives Enhanced CAR-T Cell Efficacy

Jennifer Yang, B. Engels, J. Brogdon, 2021, Blood.

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

J. Briones, I. Flinn, D. Blaise, 2023, Cancer discovery.